Charles Schwab’s Medline Inc MDLN Stock Holding History

Charles Schwab’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.1M	Buy	990,200 +210,159	+27%	+$9.28M	0.01%	1245
2025 Q4	$32.8M	Buy	+780,041	New	+$32.9M	0.01%	1433

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Charles Schwab's MDLN Position: Q1 2026 in Review

Charles Schwab increased its Medline Inc (MDLN) stake by 27% in Q1 2026, buying an estimated $9.28M and bringing the position to 990,200 shares worth $44.1M. The position accounts for 0.01% of the portfolio, ranked #1245.

Charles Schwab first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Charles Schwab held 990,200 shares of Medline Inc worth $44.1M as of Q1 2026.
Charles Schwab bought 210,159 Medline Inc shares in Q1 2026, an estimated $9.28M.
Medline Inc made up 0.01% of Charles Schwab's portfolio in Q1 2026, its #1245 holding.
Charles Schwab first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.